Simcere Pharmaceutical Co., Ltd
Simcere Pharmaceutical Co., Ltd
Explore linked clinical trials.5 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Crossover Study to Evaluate the Relative Bioavailability of Two Formulations of Deuterated Remdesivir Hydrobromide for Oral Suspension in Healthy Chinese Adults | Healthy Participants | Not yet recruiting | Phase 1 | 2026-04-03 | NCT07510529 | |
| A Phase III Study of Deuremidevir Hydrobromide for the Treatment of RSV Infection in Infants and Young Children | Infections, Mononegavirales infectious disease, Paramyxoviridae infectious disease, Pneumovirus Infections, RNA Virus Infections, respiratory syncytial virus infectious disease, viral infectious disease | Recruiting | Phase 3 | 2026-04-02 | NCT07402512 | |
| SIM0718 Treatment of Asthma Clinical Study | Eosinophilia, Hemic and Lymphatic Diseases, hematologic disorder, hypereosinophilic syndrome, leukocyte disorder, lung disorder, pulmonary eosinophilia, respiratory system disorder | Recruiting | Phase 3 | 2026-04-02 | NCT06488755 | |
| A Multicenter Phase 2a Clinical Study to Evaluate SIM0278 in Subjects With Active Lupus Nephritis | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Skin and Connective Tissue Diseases, Urogenital Diseases, autoimmune disease, connective tissue disorder, glomerulonephritis, immune system disorder, kidney disorder, lupus nephritis, nephritis, systemic lupus erythematosus, urinary system disorder | Not yet recruiting | Phase 2 | 2026-02-06 | NCT07393451 | |
| Edaravone Dexborneol Sublingual Tablet for the PSCI in Acute Ischemic Stroke Patients | Post-stroke Cognitive Impairment | Recruiting | Phase 2 | 2025-09-03 | NCT06315231 |